Frankfurt - Delayed Quote EUR

Jazz Pharmaceuticals plc (J7Z.F)

91.94

+1.88

+(2.09%)

At close: 9:55:02 PM GMT+2

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present seven abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting from May 30-June 3, 2025, in Chicago and online. The presentations will feature data from clinical trials evaluating Zepzelca® (lurbinectedin), Ziihera® (zanidatamab-hrii), Vyxeos® (daunorubicin and cytarabine) and investigational dordaviprone (ONC201).

PR Newswire 1 hour ago

JAZZ
Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak

CBOE, AGNC, JAZZ, AES and CNSWF are some of the stocks with high ROE to profit from as markets expect the tariff war to end soon.

Zacks 6 hours ago

CNSWF

AES

AGNC
3 Small-Cap Stocks in the Doghouse

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

StockStory 8 hours ago

MHK

FNKO

JAZZ
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 first quarter financial results on Tuesday, May 6, 2025, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. ET / 9:30 p.m. IST to discuss 2025 first quarter financial results and provide a business and financial update.

PR Newswire yesterday

JAZZ
Jazz Pharmaceuticals Completes Acquisition of Chimerix

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") today announced the successful completion of its acquisition of Chimerix, Inc. ("Chimerix") for approximately $935 million in cash. Chimerix is now a wholly owned subsidiary of Jazz.

PR Newswire 2 days ago

JAZZ
JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Both JAZZ and HRMY expect sales from neuroscience products to grow in 2025.

Zacks 2 days ago

HRMY

JAZZ
JAZZ vs. ARGX: Which Stock Is the Better Value Option?

JAZZ vs. ARGX: Which Stock Is the Better Value Option?

Zacks 6 days ago

JAZZ
Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 6 days ago

JAZZ
Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Not your typical cannabis play. Discover why Jazz Pharma's FDA-approved CBD drug could make it a top cannabis stock to watch in 2025.

Zacks 6 days ago

JAZZ
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.

StockStory 6 days ago

JAZZ

ANIP

VTRS
Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last?

Jazz (JAZZ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks 13 days ago

NVAX

JAZZ
JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?

We advise investors to use the price dip in JAZZ stock as a buying opportunity despite the dynamic shifts in the regulatory landscape.

Zacks 14 days ago

JAZZ
5 High ROE Stocks to Buy as Markets Face Tariff Bloodbath

ANET, GLW, JAZZ, AES and PPC are some of the stocks with high ROE to profit from as markets recoiled on tariff war.

Zacks 16 days ago

GLW

PPC

AES
After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors

Key Insights Given the large stake in the stock by institutions, Jazz Pharmaceuticals' stock price might be vulnerable...

Simply Wall St. 22 days ago

JAZZ
JAZZ or ARGX: Which Is the Better Value Stock Right Now?

JAZZ vs. ARGX: Which Stock Is the Better Value Option?

Zacks 23 days ago

JAZZ
Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against the other best mid cap biotech stocks to buy. Is the Biotech Sector Oversaturated? On March 6, Jared Holz, Mizuho health care […]

Insider Monkey 25 days ago

JAZZ
Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 27 days ago

JAZZ

ALNY

^GSPC
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 24th Annual Needham Healthcare Conference. Company management will participate in a fireside chat on Wednesday, April 9, 2025, at 9:45 a.m. PT / 12:45 p.m. ET / 5:45 p.m. IST.

PR Newswire 28 days ago

JAZZ
Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against other biotech stocks. Biotech Sector Set for Growth Amid Innovation and Investor Interest The biotechnology sector is gaining new momentum with better […]

Insider Monkey 28 days ago

JAZZ
Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 30 days ago

JAZZ

Performance Overview

Return	J7Z.F	S&P 500 (^GSPC)
YTD	-21.12%	-8.60%
1-Year	-10.30%	+6.02%
3-Year	-38.83%	+25.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Jazz Pharmaceuticals plc (J7Z.F)

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma

Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing Streak

3 Small-Cap Stocks in the Doghouse

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

JAZZ vs. ARGX: Which Stock Is the Better Value Option?

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Jazz (JAZZ) Moves 7.1% Higher: Will This Strength Last?

JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?

5 High ROE Stocks to Buy as Markets Face Tariff Bloodbath

After a year of 4.3% returns, Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) share price drop last week may have less of an impact on institutional investors

JAZZ or ARGX: Which Is the Better Value Stock Right Now?

Is Jazz Pharmaceuticals (JAZZ) the Best Mid Cap Biotech Stock to Buy?

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term

Performance Overview